DOC HEALTHPEAK PROPERTIES, INC.

DOC financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 765880 Exchange: NYSE SIC: 6798 (Real Estate Investment Trusts)
Showing 3 of 19 annual and 0 of 72 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Large accelerated filer
Entity Type
Operating
Public Float
$9.40B (Jun 2025)
Industry (SIC)
6798 Real Estate Investment Trusts
Incorporated
MD
Fiscal Year End
December (1231)
Phone
949-407-0700
EIN
330091377
Headquarters
DENVER, CO, 80237
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: HCP, INC. (2007–2019) · HEALTH CARE PROPERTY INVESTORS INC (1994–2007)

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$2.95B
Net Income
$243.30M
Total Assets
$21.68B
Total Equity
$9.47B
Total Debt
-
Free Cash Flow
-
Ratios
Net Margin
8.2%
Return on Equity
2.6%
Return on Assets
1.1%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

HEALTHPEAK PROPERTIES, INC. generated $2.82B of revenue in fiscal 2025, with net income of $71.35M and an operating cash inflow of $1.25B. The $2.82B revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. Compared with $2.70B in fiscal 2024, revenue recorded a 4.5% year-over-year increase. On a per-share basis, diluted EPS was $0.10, which connects the reported earnings outcome with the company’s diluted share count. Diluted EPS decreased by 72.2% from $0.36 in fiscal 2024, showing how the earnings change reached shareholders on a per-share basis. Diluted shares averaged 696.04M; this is the reported share base over which the company’s diluted per-share earnings were spread. Diluted shares moved 2.9% from 676.23M in fiscal 2024, leaving the current share base higher year over year. At period end, total assets were $20.34B, framing the scale of the company’s operating and financing commitments. Asset turnover was 0.14x, relating the company’s annual revenue directly to the total assets reported at the period end.

Profitability

The bottom-line result was net income of $71.35M, after the operating, financing, tax, and other items recognized for the period. Measured against reported revenue, net income produced a 2.5% margin after operating costs and the remaining recognized items. Income tax expense totaled $9.28M, providing the reported tax component that separates pretax and after-tax earnings. The relationship between net income and period-end equity was 0.9%, indicating the profitability achieved on book capital. The net-income-to-assets relationship measured 0.4%, showing earnings relative to the full balance sheet. Current net income of $71.35M was below fiscal 2024 net income of $243.14M, showing the direction of the bottom-line change.

Liquidity and Capital Structure

The company held $20.34B of assets against $12.03B of liabilities and $8.14B of equity, revealing how the asset base was financed. Reported cash and equivalents were $467.46M, separating immediately recognizable cash resources from the rest of the current-asset base. Total debt was $9.85B, establishing the amount of borrowing carried within the company’s capital structure. The debt-to-equity relationship was 1.21x, showing how much debt the company carried for each unit of book equity. The debt-to-assets relationship was 48.4%, comparing borrowing with the total asset balance. The equity-to-assets relationship was 40.0%, placing book capital against the total resource base. The liabilities-to-assets relationship was 59.2%, placing reported obligations against the full positive asset balance. The cash-to-assets relationship was 2.3%, comparing reported cash and equivalents with the full positive asset balance. Compared with $19.94B in fiscal 2024, the current asset base moved 2.0% and finished higher. Book equity was 10.1% lower than fiscal 2024 equity of $9.06B, showing how shareholder capital changed year over year. Cash and equivalents were 290.1% higher than fiscal 2024 cash of $119.82M, showing the year-over-year change in liquid resources.

Cash Flow and Earnings Quality

Cash flow from operations was $1.25B, a reported cash inflow that can be compared directly with net income and capital spending. Operating cash flow equaled 17.55x of net income, showing how strongly accounting earnings converted into cash from operations. The cash-flow statement records $894.95M of capital expenditures, the investment amount considered after operating cash generation. Capital expenditures represented 71.5% of operating cash flow, leaving the remainder available as free cash flow. Free cash flow came to $357.01M, leaving a positive amount after capital expenditures. Relative to revenue, free cash flow equaled 12.6%, showing how much sales converted into cash after investment. The free-cash-flow-to-assets relationship was 1.8%, comparing post-investment cash with the balance-sheet asset base. Operating cash flow of $1.25B finished above fiscal 2024 operating cash flow of $1.07B, showing the year-over-year direction of cash generation.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual (FY)
Quarterly 🔒
Chart 🔒
Annual financial statements for HEALTHPEAK PROPERTIES, INC.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $2.82B $2.70B $2.18B
Cost of Revenue - $1.07B $902.06M
Gross Profit - $1.63B $1.28B
OPERATING EXPENSES
SG&A Expense $90.42M $97.16M $95.13M
NON-OPERATING INCOME / EXPENSE
Interest Expense $305.18M $280.43M $200.33M
Other Income/Expense $479.00K $59.35M $6.81M
Income Tax $9.28M $4.35M $-9.62M
Net Income $71.35M $243.14M $306.01M
PER SHARE & SUPPLEMENTAL
Diluted EPS $0.10 $0.36 $0.56
Diluted Shares 696.04M 676.23M 547.28M
Depreciation & Amortization $1.06B $1.06B $749.90M
Balance Sheet
ASSETS
Cash & Equivalents $467.46M $119.82M $117.64M
Accounts Receivable $78.33M $76.81M $55.82M
Goodwill $68.53M $68.53M $18.03M
Intangible Assets $654.52M $817.25M $314.16M
Other Noncurrent Assets $885.16M $819.95M $772.04M
Total Assets $20.34B $19.94B $15.70B
LIABILITIES
Long-term Debt $9.85B $8.72B $6.88B
Total Liabilities $12.03B $10.88B $8.77B
EQUITY
Common Stock $695.04M $699.49M $547.16M
Additional Paid-in Capital $12.77B $12.85B $10.41B
Accumulated OCI $-9.94M $28.82M $19.37M
Total Equity $8.14B $9.06B $6.88B
Redeemable NCI $159.58M $2.61M $48.83M
Total Liabilities & Equity $20.34B $19.94B $15.70B
SUPPLEMENTAL
Shares Outstanding 695.04M 699.49M 547.16M
Check: A − (L + E + NCI) - - -
Cash Flow Statement
Cash from Operations $1.25B $1.07B $956.24M
Capital Expenditures $894.95M $736.76M $774.56M
Cash from Investing $-1.03B $-113.80M $-576.75M
Cash from Financing $136.11M $-941.42M $-337.30M
Free Cash Flow $357.01M $333.73M $181.68M
Beginning Cash (CFS) $184.31M $169.02M -
Net Change in Cash $353.40M $15.28M -
Effect of FX on Cash - - -
Calculated Ending Cash $537.70M $184.31M -
Cash per BS $467.46M $119.82M $117.64M
Cash scope difference (CFS − BS) $70.25M $64.49M $51.39M
Cash per CFS $537.70M $184.31M $169.02M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is HEALTHPEAK PROPERTIES, INC.'s annual revenue?

HEALTHPEAK PROPERTIES, INC. reported $2.95B in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is HEALTHPEAK PROPERTIES, INC. profitable?

Yes. HEALTHPEAK PROPERTIES, INC. reported $243.30M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.